港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

醫美概念股

885.162

-4.922-0.55%

漲家數：3

跌家數：6

平家數：4

市盈率：- -

高：889.747

開：889.747

低：879.542

收：890.084

成交量：1,326.76萬

成交額：1.39億

市值：1,475.91億

流通市值：1,084.53億

資料載入中...

總覽新聞資訊

【券商聚焦】中信建投：醫療器械板塊業績有望逐步改善

【券商聚焦】中信證券：上半年CXO及生命科學上游板塊整體表現穩健，CRO有望量價齊升

三生製藥(01530)9月10日斥資6262.93萬港元回購400萬股

昊海生物科技(06826)9月10日耗資約79.57萬港元回購4.8萬股

昊海生物科技(06826.HK)9月10日耗資約79.57萬港元回購4.8萬股

復星醫藥(02196)股價下跌5.032%，現價港幣$16.42

阿斯达克财经

三生製藥(01530)出現大手賣出56.2萬股，成交價$15.6，涉資876.72萬

阿斯达克财经

四環醫藥(00460)出現大手賣出210萬股，成交價$0.73，涉資153.3萬

阿斯达克财经

多家藥企處置資產反哺主業

復星醫藥白癜風口服新藥獲批III期臨床

復星醫藥(02196)9月9日斥資262.98萬港元回購15.25萬股

康哲藥業(00867.HK)狂犬雙特異性抗體「金速希」全國首批處方落地

阿斯达克财经

《大行》里昂：中國創新藥板塊重返Alpha主導宏觀波動或提供買入機會

阿斯达克财经

昊海生物科技(06826)9月8日斥資52.93萬港元回購3.15萬股

復星醫藥(600196.SH)子公司FXS5626片獲臨床試驗批准

復星醫藥：控股子公司藥品FXS5626獲臨床試驗批准

復星醫藥(02196)9月7日斥資117.52萬港元回購7萬股

昊海生物科技(06826.HK)9月7日耗資約109.63萬港元回購6.55萬股

復星醫藥控股股東質押3.3億股還債累計質押比例超7成

復鋭醫療科技(01696)股價上升5.277%，現價港幣$1.995

阿斯达克财经

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BK1593/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"醫美概念股","latestPrice":885.16235,"timestamp":1789527897736,"preClose":890.084,"halted":0,"volume":13267580,"delay":0,"changeRate":-0.005529,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-4.921631,"latestTime":"09-16 11:05:10","open":889.7474,"high":889.7474,"low":879.5415,"amount":138609695,"amplitude":0.011466,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"午間休市","tradingStatus":4,"beginTime":1789531200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"pbRate":1.136925,"peRate":10.390002,"turnoverRate":0.000665,"increases":3,"decrements":6,"flats":4,"marketCap":147591347160,"floatMarketCap":108452769496},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":889.7474,"amplitude":0.011466,"preClose":890.084,"low":879.5415,"pbRate":"1.136925","latestPrice":885.16235,"volume":13267580,"delay":0,"open":889.7474,"prevYearClose":1094.978,"prevWeekClose":869.902,"prevMonthClose":902.195,"prevQuarterClose":846.145,"fiveDayClose":916.041,"twentyDayClose":932.26,"sixtyDayClose":841.364,"secType":"PLATE","market":"HK","turnoverRate":0.000665,"peRate":10.390002,"marketCap":147591347160,"floatMarketCap":108452769496,"timestamp":1789527897736,"nameCN":"醫美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":3,"down":6,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666127155","title":"【券商聚焦】中信建投：醫療器械板塊業績有望逐步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2666127155","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666127155?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:18","pubTimestamp":1789089493,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。该机构认为，随着集采影响逐步出清叠加创新驱动和海外业务加速的双重助力，医疗器械板块业绩有望逐步改善。尽管季度业绩增速可能有所波动，Q3能否相比Q2加速尚不确定，但大趋势来看，26和27年年度业绩持续改善的确定性较强。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991348","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066","09996","BK1617","BK1591","BK1583","01302","HART","BK1161","LNGR","BK1189","LU0287142896.SGD","02252","BK1571","RSPH","BK1615","BK1100","02190","02235","06826","BK1247","GDOC","BK1585","601066","BK1589","BK1600","LGHT","BK1587","BK1515","IEIH","PTH","AGNG","BK1501","00241","BK1610","BK0276","KCE","LU0173614495.USD","HK0000165453.HKD","BK1584","00853","MDEV","MEDX","BK1142","BK1222","BK1502","BK1593","159883","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666917512","title":"【券商聚焦】中信證券：上半年CXO及生命科學上游板塊整體表現穩健，CRO有望量價齊升","url":"https://stock-news.laohu8.com/highlight/detail?id=2666917512","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666917512?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:07","pubTimestamp":1789088866,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研究指，2026年上半年，CXO板块及生命科学上游板块整体业绩表现稳健，行业进入复苏阶段。上半年海外投融资景气度持续，美联储加息预期走弱，早研板块整体的景气度持续走强，AIDD的快速发展也将进一步催化未来相关实验和验证需求的爆发，该机构认为CRO板块有望量价齐升。CDMO板块上半年龙头业绩表现稳健，整体订单增速持续加快，行业景气度回升。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991341","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","LU1997244956.HKD","BK1574","LU2328871848.SGD","06030","09688","BK0028","BK1500","02228","LU1997245177.USD","SG9999014674.SGD","01530","06821","BK1100","LU0634319403.HKD","600030","LU0348827113.USD","CXO","LU0348783233.USD","BK0188","LU1794554557.SGD","SG9999004311.SGD","01789","LU0463099449.HKD","LU2778985437.USD","BK0196","WX","02196","02367","LU1188198961.HKD","01099","BK1593","LU2476274308.USD","LU1969619763.USD","LU1997245094.SGD","LU0244354667.USD","LU0561508036.HKD","LU1146622755.USD","LU2495084118.USD","09926","LU0417516902.SGD","LU0405327494.USD","KCE","KURE","LU0540923850.HKD","03933","BK1521","IE00B3M56506.USD","02268","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666673645","title":"三生製藥(01530)9月10日斥資6262.93萬港元回購400萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666673645","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666673645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 18:36","pubTimestamp":1789036592,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生制药(01530)发布公告，于2026年9月10日，该公司斥资6262.93万港元回购400万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","HK0000165453.HKD","BK1593","01530","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666610625","title":"昊海生物科技(06826)9月10日耗資約79.57萬港元回購4.8萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666610625","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666610625?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 17:41","pubTimestamp":1789033302,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)公布，2026年9月10日耗资约79.57万港元回购4.8万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666060561","title":"昊海生物科技(06826.HK)9月10日耗資約79.57萬港元回購4.8萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666060561","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666060561?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 17:41","pubTimestamp":1789033302,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","BK1161","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666549805","title":"復星醫藥(02196)股價下跌5.032%，現價港幣$16.42","url":"https://stock-news.laohu8.com/highlight/detail?id=2666549805","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666549805?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 10:54","pubTimestamp":1789008840,"startTime":"0","endTime":"0","summary":"[下跌股]复星医药(02196) 股价在上午10:53比前收市价下跌5.032%，现股价为港币$16.42。至目前为止，今日最高价为$17.2，而最低价为$16.42。总成交量为368.176万股，总成交金额为港币$6.135千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609101759/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609101759/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0183","BK1593","BK0012","BK0196","BK1191","BK1515","02196","BK0060","BK0239","BK0188","BK0187","BK0096","600196","BK0175","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666554961","title":"三生製藥(01530)出現大手賣出56.2萬股，成交價$15.6，涉資876.72萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2666554961","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666554961?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 10:53","pubTimestamp":1789008780,"startTime":"0","endTime":"0","summary":"[大手成交]三生制药(01530)在上午10:53出现大手卖出，成交量为56.2万，成交价为港币$15.6，涉资876.72万。至目前为止，股价跌3.344%，今日最高价为$16.12，而最低价为$15.6，总成交量为1.626千万股，总成交金额港币$2.554亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609104122/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609104122/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1593","BK1583","BK1161","HK0000165453.HKD","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666368551","title":"四環醫藥(00460)出現大手賣出210萬股，成交價$0.73，涉資153.3萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2666368551","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666368551?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 09:45","pubTimestamp":1789004700,"startTime":"0","endTime":"0","summary":"[大手成交]四环医药(00460)在上午09:45出现大手卖出，成交量为210万，成交价为港币$0.73，涉资153.3万。至目前为止，股价跌4.516%，今日最高价为$0.775，而最低价为$0.73，总成交量为2.484千万股，总成交金额港币$1.856千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2609101869/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2609101869/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","00460","BK1515","BK1593","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666539022","title":"多家藥企處置資產反哺主業","url":"https://stock-news.laohu8.com/highlight/detail?id=2666539022","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666539022?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 22:59","pubTimestamp":1788965940,"startTime":"0","endTime":"0","summary":"除此之外，今年以来，多瑞医药先后将厦门瑞蒂莲69%股权转让给关联方西藏嘉康时代科技发展有限公司，属于首批处置的非核心资产；为了剥离低效制剂相关业务，多瑞医药还将湖北海瑞迪100%股权全部转让给关联方西藏嘉康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2026-09-09/doc-inirfytq8374634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09939","BK1574","02196","BK1515","BK1593","BK1161","BK1191","BK4202","FOSL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538734","title":"復星醫藥白癜風口服新藥獲批III期臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538734","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538734?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 19:42","pubTimestamp":1788954120,"startTime":"0","endTime":"0","summary":"近日，复星医药宣布，FXS5626片（原项目代号：AC-201）用于治疗非节段型白癜风开展II/III期适应性无缝设计临床试验已获药监局批准。从进度看，辉瑞利特昔替尼和诺诚健华soficitinib处于第一梯队，均已公布积极II/III期数据。复星医药FXS5626与华东医药VC005、恒瑞艾玛昔替尼大致处于第二梯队。 且国内白癜风口服在研管线中，FXS5626是目前唯一明确标注为TYK2/JAK1双靶点的品种。运营｜廿十三","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-09/doc-inirfums8444408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK1593","600196","BK0012","BK0196","BK1515","BK0060","BK0183","BK0096","BK0175","02196","BK0028","BK0239","BK1191","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666843785","title":"復星醫藥(02196)9月9日斥資262.98萬港元回購15.25萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666843785","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666843785?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:03","pubTimestamp":1788948238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，于2026年9月9日，该公司斥资262.98万港元回购15.25万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493968.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600196","BK0175","BK0183","BK1191","BK1515","02196","BK0060","BK0239","BK0096","BK0196","BK0188","BK0187","BK0028","BK1593","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666058130","title":"康哲藥業(00867.HK)狂犬雙特異性抗體「金速希」全國首批處方落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2666058130","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666058130?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 17:28","pubTimestamp":1788946080,"startTime":"0","endTime":"0","summary":"康哲药业公布，一类创新药“金速希”近日在全国多地开出首批处方，覆盖首都医科大学附属北京潞河医院、温州市人民医院等多家医疗机构，标志着全球首款狂犬病被动免疫双特异性抗体正式进入规模化临床应用。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230303150406244_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230303150406244_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543675/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543675/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["00867","SG9999015978.USD","IE00BVYPNP33.GBP","LU2488822045.USD","BK1191","BK1593","SG9999004220.SGD","SG9999015945.SGD","SG9999015986.USD","SG9999015952.SGD","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","IE00BGHQDM52.EUR","SG9999004311.SGD","IE00BYV24P56.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666304134","title":"《大行》里昂：中國創新藥板塊重返Alpha主導  宏觀波動或提供買入機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2666304134","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666304134?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 12:08","pubTimestamp":1788926880,"startTime":"0","endTime":"0","summary":"里昂发表报告指，中国创新药板块正重回以公司基本面与个股超额收益为主导的市场，公司特定基本面相对宏观因素的影响力回升。该行预期，随市场对创新药企临床及BD执行信心改善，基本面角色将愈趋重要；短期宏观波动或提供趁低买入、验证此观点的机会。该行认为，重大临床读出与BD活动加速，正面催化剂窗口正在打开。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220210100852532_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220210100852532_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543577/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543577/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1720050803.USD","LU1255011170.USD","LU2097828805.USD","IE00BYV24P56.USD","BK1593","IE00BZ08YS42.EUR","IE00B031HY20.USD","603259","LU0327786744.USD","LU0502904849.HKD","LU2399975544.HKD","LU1152091754.HKD","LU1188198961.HKD","LU0140636845.USD","LU0540923850.HKD","LU0708995583.HKD","LU0417516571.SGD","01099","LU1820825898.SGD","LU2097828631.EUR","603233","LU0463099449.HKD","LU1046422090.SGD","LU1655091616.SGD","SG9999015978.USD","BK0226","LU0417516738.SGD","LU1961090484.USD","IE00BVYPNQ40.USD","LU1831875114.USD","SHTDY","LU0326950275.SGD","BK0028","LU0405327148.USD","LU1328615791.USD","LU0348827113.USD","LU1152091168.USD","BK0239","LU1064131003.USD","LU0320764599.SGD","LU0572944931.SGD","LU1951186391.HKD","03692","HK0000165453.HKD","LU1226288170.HKD","LU1997245177.USD","LU2148510915.USD","BK1589","BK1141","BK1574","BK1587","SG9999015945.SGD","LU1115378108.SGD","LU2580892789.USD","LU2580892862.HKD","LU1226288253.USD","LU1813983027.USD","02162","LU0880133367.SGD","IE00BVYPNP33.GBP","LU2476274720.SGD","LU2097828714.EUR","LU1226287529.USD","BK0196","LU0348735423.USD","LU0455707207.USD","BK0188","IE00BMCWC346.EUR","LU1794554557.SGD","BK0114","SG9999015952.SGD","09926","00867","LU0607220059.USD","LU1781817850.SGD","02595","IE00BZ08YR35.GBP","LU1146622755.USD","BK0012","SG9999004220.SGD","BK1161","LU0348766576.USD","BK1521","LU0244354667.USD","LU1969619763.USD","LU1993786604.SGD","LU0348784397.USD","LU1960683339.HKD","SBHMY","LU0315179316.USD","LU2125910500.SGD","LU0348783233.USD","KURE","LU2476274308.USD","LU0640798160.USD","BK1191","IE00B5MMRT66.SGD","LU1997244956.HKD","LU0348825331.USD","BK1500","BK1583","LU1328277881.USD","LU0501845795.SGD","LU1008478684.HKD","LU2495084118.USD","01177","LU1807302812.USD","LU0072913022.USD","LU2097828557.USD","300765","BK1197","IE00BPRC5H50.USD","IE00BGHQDM52.EUR","LU2778985437.USD","LU2045819591.USD","BK0209","IE0008369823.USD","LU2328871848.SGD","LU2242644610.SGD","BK1515","01801","LU0348767384.USD","LU0149534421.HKD","LU1226287792.SGD","LU0314109678.HKD","600276","BK0060","SG9999015986.USD","LU0052750758.USD","LU2039709279.SGD","LU0417516902.SGD","BK1576","IE00BZ08YT58.USD","IE00B543WZ88.USD","IE0008368742.USD","LU0067412154.USD","LU2289578879.USD","LU2488822045.USD","BK0185","01093","LU0405327494.USD","LU1997245094.SGD","LU0469268626.HKD","BK0183","LU1064130708.USD","02359","LU2097828474.EUR","01276","LU1580142542.USD","LU0634319403.HKD","SG9999004311.SGD","LU1226287875.USD","LU0561508036.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665507329","title":"昊海生物科技(06826)9月8日斥資52.93萬港元回購3.15萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665507329","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665507329?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:43","pubTimestamp":1788860639,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2026年9月8日斥资52.93万港元回购3.15万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493397.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665132698","title":"復星醫藥(600196.SH)子公司FXS5626片獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2665132698","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665132698?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:13","pubTimestamp":1788858794,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药 发布公告，近日，公司控股子公司上海复星医药产业发展有限公司收到国家药品监督管理局关于同意FXS5626片用于治疗非节段型白癜风开展II/III期适应性无缝设计临床试验的批准。复星医药产业拟于条件具备后于中国境内开展该药品的相关临床研究。截至2026年8月，公司现阶段针对FXS5626的累计研发投入约为1.08亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0188","BK1593","BK0187","600196","BK0012","BK0096","BK0239","IBBQ","BK0028","BK0060","IBBJ","PSYK","BMED","BK0196","BK1515","MDTX","BK0175","02196","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665732638","title":"復星醫藥：控股子公司藥品FXS5626獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2665732638","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665732638?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:59","pubTimestamp":1788857986,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1515","BK0187","BK0239","BK0183","02196","600196","BK0096","BK0175","BK0028","BK1191","BK0188","BK1593","BK0060","BK0196","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315565","title":"復星醫藥(02196)9月7日斥資117.52萬港元回購7萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315565","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315565?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:00","pubTimestamp":1788775238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，于2026年9月7日，该公司斥资117.52万港元回购7万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492862.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK0196","BK0239","BK0175","BK0096","BK0060","600196","BK0188","BK0028","02196","BK0012","BK0187","BK1191","BK1515","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665631893","title":"昊海生物科技(06826.HK)9月7日耗資約109.63萬港元回購6.55萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665631893","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665631893?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:51","pubTimestamp":1788771106,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","BK1161","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392895","title":"復星醫藥控股股東質押3.3億股還債 累計質押比例超7成","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392895","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392895?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:37","pubTimestamp":1788763023,"startTime":"0","endTime":"0","summary":"中国经济网北京9月7日讯 复星医药 9月5日披露的关于股东部分股份质押的公告显示，公司于2026年9月4日接到控股股东上海复星高科技(集团)有限公司的通知，其已将所持有的公司部分A股股份办理质押手续。　　复星高科技本次质押股份数量为3.3亿股，占其所持股份数比例的34.32%，占公司股份总数比例为12.36%。质押起始日为2026年9月3日，质押到期日为2028年9月8日。　　控股股东复星高科技质押公司股份均系用于融资。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/07/20260907896860.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/07/20260907896860.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260907/32361887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0012","BK1191","BK0196","BK1593","BK1515","600196","BK0096","BK0187","BK0028","BK0060","BK0183","BK0188","02196","BK0239","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665215394","title":"復鋭醫療科技(01696)股價上升5.277%，現價港幣$1.995","url":"https://stock-news.laohu8.com/highlight/detail?id=2665215394","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665215394?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:20","pubTimestamp":1788762000,"startTime":"0","endTime":"0","summary":"[上升股]复锐医疗科技(01696) 股价在下午02:19比前收市价上升5.277%，现股价为港币$1.995。至目前为止，今日最高价为$1.995，而最低价为$1.925。总成交量为6.76万股，总成交金额为港币$13.255万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609073415/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609073415/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1593","BK1100","BK1585","01696"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":69,"code":"91000000","status":"200"}]}}